# Kovai Medical Center & Hospital (NSE: KOVAI) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/KOVAI · Pivot · prices to 22 Oct 2026

Kovai Medical Center & Hospital (NSE: KOVAI) closed at ₹5,738.00 on 22 Oct 2026, down 2.24% on the day. With a market capitalisation of ₹6,279 Cr, it ranks 699th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 25.7× trailing earnings, against a return on equity of 20.1% in FY18. Over the past year the share price has risen 190.4%. Its 52-week range is ₹5,275.50 (27 May 2026) to ₹6,444.00 (10 Sep 2026); the last close is 11.0% below the high. Promoters held 56.52% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹5,738.00 |
| Market cap | ₹6,279 Cr |
| P/E (trailing) | 25.7 |
| ROE | 20.1% (FY18) |
| ROCE | 11.6% (FY18) |
| Debt to equity | 0.57 |
| 52-week high | ₹6,444.00 (10 Sep 2026) |
| 52-week low | ₹5,275.50 (27 May 2026) |
| 1-year return | +190.4% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY18 | ₹592 Cr | ₹58 Cr |
| FY17 | ₹531 Cr | ₹60 Cr |
| FY16 | ₹465 Cr | ₹41 Cr |
| FY15 | ₹402 Cr | ₹39 Cr |
| FY14 | ₹334 Cr | ₹24 Cr |
| FY13 | ₹297 Cr | ₹20 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 56.52%
- Foreign institutions: 1.25%
- Domestic institutions: 4.25%
- Non-institutions: 37.98%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Morepen Laboratories](https://app.pivotnow.in/stock/MOREPENLAB) | ₹125.70 | ₹6,888 Cr | 72.7 | — |
| [Supriya Lifescience](https://app.pivotnow.in/stock/SUPRIYA) | ₹848.80 | ₹6,831 Cr | 32.7 | — |
| [Bliss GVS Pharma](https://app.pivotnow.in/stock/BLISSGVS) | ₹638.00 | ₹6,766 Cr | 53.1 | — |
| [Sanofi India](https://app.pivotnow.in/stock/SANOFI) | ₹2,845.00 | ₹6,552 Cr | 21.2 | — |
| [Entero Healthcare Solutions](https://app.pivotnow.in/stock/ENTERO) | ₹1,504.20 | ₹6,547 Cr | 57.1 | — |
| [Nephrocare Health Services](https://app.pivotnow.in/stock/NEPHROPLUS) | ₹599.90 | ₹6,019 Cr | 74.1 | — |

## Questions and answers

### What is the share price of Kovai Medical Center & Hospital today?

Kovai Medical Center & Hospital (NSE: KOVAI) last closed at ₹5,738.00 on 22 Oct 2026. Its 52-week high is ₹6,444.00 and its 52-week low is ₹5,275.50.

### What is the market cap of Kovai Medical Center & Hospital?

Kovai Medical Center & Hospital's market capitalisation is ₹6,279 Cr (₹6,279 Cr) at the 22 Oct 2026 close, ranking 699th among the NSE companies Pivot tracks.

### What is the P/E ratio of Kovai Medical Center & Hospital?

Kovai Medical Center & Hospital trades at a trailing P/E of 25.7. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 57.1.

### What is the ROE and ROCE of Kovai Medical Center & Hospital?

Return on equity was 20.1% in FY18 and return on capital employed was 11.6% in FY18 (consolidated figures).

### Is Kovai Medical Center & Hospital a debt-free company?

No. Kovai Medical Center & Hospital's debt-to-equity ratio was 0.57 in FY18, with total debt of ₹165 Cr.

### How has Kovai Medical Center & Hospital stock performed over the last year?

Kovai Medical Center & Hospital's share price has risen 190.4% over the past year, −1.6% over three months and −7.3% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Kovai Medical Center & Hospital?

As of 30 Jun 2026: promoters 56.52%, foreign institutions 1.25%, domestic institutions 4.25%, non-institutions 37.98%.

### Who are Kovai Medical Center & Hospital's competitors?

The listed Pharma & Healthcare companies closest to Kovai Medical Center & Hospital by market cap are Morepen Laboratories, Supriya Lifescience, Bliss GVS Pharma, Sanofi India, Entero Healthcare Solutions and Nephrocare Health Services.

### Is Kovai Medical Center & Hospital a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Kovai Medical Center & Hospital's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on KOVAI against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.